Greenwich LifeSciences, Inc. (GLSI)

Greenwich LifeSciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	8.88	6.18	4.09	6.99	13.47	27.2
Cash & Short-Term Investments	8.88	6.18	4.09	6.99	13.47	27.2
Cash Growth	184.03%	50.98%	-41.45%	-48.10%	-50.49%	-5.08%
Total Current Assets	8.88	6.18	4.09	6.99	13.47	27.2
Other Intangible Assets	-	-	0	0.01	0.01	0.01
Total Assets	8.88	6.18	4.09	6.99	13.48	27.22
Accounts Payable	4.81	4.65	2.58	0.04	-	-
Accrued Expenses	0.95	1.17	0.6	0.26	0.26	0.39
Total Current Liabilities	5.76	5.82	3.19	0.29	0.26	0.39
Total Liabilities	5.76	5.82	3.19	0.29	0.26	0.39
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	99.85	87.48	68.67	57.05	54.67	60.47
Retained Earnings	-96.74	-87.14	-67.78	-50.36	-41.47	-33.65
Total Common Equity	3.12	0.35	0.91	6.7	13.21	26.83
Shareholders' Equity	3.12	0.35	0.91	6.7	13.21	26.83
Total Liabilities & Equity	8.88	6.18	4.09	6.99	13.48	27.22
Net Cash (Debt)	8.88	6.18	4.09	6.99	13.47	27.2
Net Cash Growth	184.03%	50.98%	-41.45%	-48.10%	-50.49%	-4.16%
Net Cash Per Share	0.62	0.46	0.31	0.54	1.04	2.10
Filing Date Shares Outstanding	14.68	14.68	13.27	12.88	12.85	12.95
Total Common Shares Outstanding	14.68	14.3	13.15	12.85	12.85	13.15
Working Capital	3.12	0.35	0.91	6.7	13.21	26.82
Book Value Per Share	0.21	0.02	0.07	0.52	1.03	2.04
Tangible Book Value	3.12	0.35	0.91	6.7	13.21	26.82
Tangible Book Value Per Share	0.21	0.02	0.07	0.52	1.03	2.04

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 11, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 17, 2026

Data Sources Report a data error